Global Hemostats Market valued at $2.7 billion in 2021, is set to witness a growth of 6% by 2026

BRUSSELS - July 5, 2022 - PRLog -- Hemostasis is the body's natural reaction to an injury that stops bleeding and repairs the damage. The capability helps in conserving blood and prevents infection. Hemostats are surgical tools that are used in surgical procedures to control bleeding.

Plastic Surgery - An Untapped and Emerging Market

Plastic surgery represents a commercially opportunity for the hemostats market. Similar to other surgical procedures, plastic surgery procedures are also not without associated complications. Seromas and hematomas are relatively common complications associated with plastic surgery procedures. These complications severely impact wound healing and result in substantial morbidity in patients. The use of hemostatic agents can reduce these complications, achieve immediate hemostasis for the local bleeding site, allow earlier drain removal, and potentially avoid the use of drains altogether.

Emerging Regions Expected to Drive the Hemostatic Agents Market

Emerging markets such as China, India, and South Korea are expected to witness a healthy and double-digit growth in the upcoming years. The growth in the emerging markets is likely to be driven by lower-priced hemostatic products that are largely commoditized. The huge volume of surgical procedures, rising cases of trauma injuries, increasing cases of organ transplantation and growing capabilities of surgeons to undertake more complex procedures that require efficacious, fast-acting hemostats to control bleeding are some of the key factors that are expected to fuel the demand of hemostatic agents in emerging markets.

"Technologically advanced products are likely to be successful in the market. I think, there is only one product in the market that has complementary characteristics of advanced bleeding control and antimicrobial activity." -Director, Hemostat Manufacturer, US

Growth Strategies Adopted by Market Players to Establish Their Stronghold

The global hemostats market is marked by the presence of both established and emerging players. Players operating in the hemostats market have adopted both organic and inorganic growth strategies such as new product launches, and acquisitions to garner larger market share.

The global hemostats market is set to grow consistently due to an increase in surgical procedure volumes, increasing usage of hemostats in military, emergency medical services (EMS) & hospitals, and commercial opportunities in minimally invasive surgery (MIS), plastic surgery, and knee replacement surgery.

Competitive Landscape Analysis: Global Hemostats Market

The global hemostats market is marked by the presence of  top market players such as Baxter, Ethicon, B. Braun, Becton Dickinson, Pfizer, CryoLife, Teleflex (Z-Medica), Integra LifeSciences, Biomup, Medtronic, etc.

Browse Detailed and Granular Research Insights on Hemostats Market @ https://meditechinsights.com/hemostats-market/